Early clinical response as a predictor of subsequent response to ixekizumab treatment: Results from a phase II study of patients with moderate-to-severe plaque psoriasis

B. Zhu, E. Edson-Heredia, G. S. Cameron, W. Shen, J. Erickson, D. Shrom, P. Wang, S. Banerjee, K. B. Gordon*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Early clinical response as a predictor of subsequent response to ixekizumab treatment: Results from a phase II study of patients with moderate-to-severe plaque psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences